Chenguang Biotech Group Co (SZSE:300138) Net Income From Continuing Operations : ¥387 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Chenguang Biotech Group Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Chenguang Biotech Group Co's net income from continuing operations for the three months ended in Mar. 2024 was ¥33 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ¥387 Mil.

Chenguang Biotech Group Co Net Income From Continuing Operations Historical Data

The historical data trend for Chenguang Biotech Group Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chenguang Biotech Group Co Net Income From Continuing Operations Chart

Chenguang Biotech Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

189.85

266.14

350.60

436.09

494.17

Chenguang Biotech Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															139.94	174.95	101.22	78.06	32.99

Chenguang Biotech Group Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥387 Mil.

Chenguang Biotech Group Co (SZSE:300138) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Chenguang Biotech Group Co Ltd (SZSE:300138) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

N/A

Address

Number 1 Chenguang Road, Hebei Province, Quzhou, CHN, 057250

Website

http://www.cn-cg.com

Chenguang Biotech Group Co Ltd is engaged in the processing of agricultural products and herb extracts in China. Its products include natural colors, including paprika oleoresin, marigold oleoresin, curcumin, red rice red, red cabbage, and red beet; and natural spice extracts and essential oils, such as capsicum oleoresin, zanthoxylum oil and oleoresin, black pepper oil and oleoresin, ginger oil and oleoresin, turmeric oil, star anise oil and oleoresin, cumin oil and oleoresin, garlic oil and oleoresin, and common fennel oil and oleoresin.

Executives

Li Feng Fei	Executives
Zhou Jing	Directors, Directors, and Executives
Li Yue Zhai	Director
Lian Yun He	Executives
Chen Yun Xia	Executives
Zhao Tao	Supervisors
Yuan Xin Ying	Supervisors
Liu Zhang Lin	Independent director
Lu Qing Guo	Directors, executives
Zhou Fang Sheng	Independent director
Wang Shu Hong	Independent director
Liu Ying Shan	Director
Han Wen Jie	Executives
Liu Dong Ming	Supervisors
Yang Wen Fang	Supervisors

Chenguang Biotech Group Co (SZSE:300138) Headlines

No Headlines